Clinical Trial Update: HBV Vaccine in Anti-core Positive Donors After LT [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on an HBV vaccine in anti-core positive donors after liver transplant (HBV reactivation condition).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• HBV vaccine (hepatitis B vaccine)

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: Hepatitis B Reactivation | Phase 2 | Status: UNKNOWN